TAS2R64P: A Potential Drug Target for Chronic Pain (G338412)

Target Name: TAS2R64P

NCBI ID: G338412

TAS2R64P

Other Name(s): T2R64P | T2R64 | Taste 2 receptor member 64 pseudogene | taste 2 receptor member 64 pseudogene | PS2

TAS2R64P: A Potential Drug Target for Chronic Pain

TAS2R64P, or T2R64P, is a protein that is expressed in the brain and is known for its role in the regulation of pain signaling. It is a potential drug target for the treatment of chronic pain conditions such as chronic non-cancer pain.

TAS2R64P is a transmembrane protein that is expressed in the brain and is involved in the regulation of various signaling pathways that are involved in pain signaling. It is a key regulator of the Pain signaling pathway, which is involved in the transmission of pain signals from the body to the brain.

TAS2R64P is involved in the regulation of the release of neurotransmitters, such as opioids and serotonin, which are involved in pain signaling. It does this by interacting with a variety of different receptors, including GPR55 and GPR85. These receptors are involved in the regulation of pain sensitivity and the perception of pain.

TAS2R64P is also involved in the regulation of the activity of other proteins that are involved in pain signaling. For example, it has been shown to interact with the protein TrkB, which is involved in the regulation of neurotransmitter release.

TAS2R64P is a potential drug target for the treatment of chronic pain conditions because of its involvement in the regulation of pain signaling. By targeting the activity of TAS2R64P, researchers may be able to develop new treatments for chronic pain conditions.

In addition to its potential as a drug target, TAS2R64P is also a potential biomarker for the assessment of pain severity. The activity of TAS2R64P has been shown to be involved in the regulation of pain sensitivity, which is a key predictor of pain severity. This suggests that TAS2R64P may be a useful biomarker for the assessment of pain severity in individuals with chronic pain conditions.

Overall, TAS2R64P is a protein that is involved in the regulation of pain signaling and has the potential to be a drug target or biomarker for the treatment of chronic pain conditions. Further research is needed to fully understand its role and potential as a therapeutic target.

Protein Name: Taste 2 Receptor Member 64 Pseudogene

The "TAS2R64P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TAS2R64P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets